Practitioner attitudes to clozapine initiation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: Clozapine is the most effective antipsychotic for treatment‐resistant schizophrenia. It is recommended as third‐line treatment for schizophrenia in national and local guidelines. Despite this, it is underutilised. This survey aimed to clarify barriers to prescribing and elucidate factors that may improve patient access to clozapine. Method: A questionnaire was made available to all staff members at South London and Maudsley NHS Foundation Trust. Results: In total, 144 clinical staff completed the questionnaire. The majority (81%) of respondents were ‘fairly’ or ‘very’ familiar with clozapine prescribing guidelines. Barriers to prescribing most commonly stated as being ‘very frequently’ a problem were patient concerns about tolerability of clozapine or patient refusal to adhere to blood test monitoring. Staff members also felt medical complications frequently prevented clozapine prescription. Dedicated staff or day hospital placements devoted to clozapine initiation were identified as factors most likely to increase prescribing of clozapine. Conclusion: Professionals identified the dominant barriers to prescribing as being patient focussed – refusal of blood test monitoring or concerns about tolerability. Clinician fears about compliance or medical complications were also important. The development of out‐patient services specifically tasked with initiating clozapine may help to increase the frequency of prescribing of clozapine earlier in treatment than is currently seen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 4×
“delays in obtaining an admission) 40 (48) 13 (15) 13 (15) 7 (8) 28 (33) 119 Cost of clozapine medication 82 (99) 1 (1) 1 (1) 0 (0) 17 (20) 121 Concerns about tolerability 35 (42) 33 (40) 20 (24) 7 (8) 6 (7) 121 Significant medical factors/Compliance 21 (25) 36 (44) 24 (29) 13 (16) 6 (7) 121”
BackgroundInfluentialClozapine Eligibility Among State Hospital Patients
Essock, S. M., Hargreaves, W. A., Dohm, F.-A., Goethe, J., Carver, L., & Hipshman, L. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.1.15 · Cited by 107
Cited by
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationInternational trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study
Wimberley, T., Støvring, H., Sørensen, H. J., Horsdal, H. T., MacCabe, J. H., & Gasse, C. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00575-1 · Cited by 153
Baandrup, L. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13384 · Cited by 79
Metadata
- Authors
- Gee, S., Vergunst, F., Howes, O., & Taylor, D.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2013-09-05
- Volume
- 130
- Issue
- 1
- Pages
- 16-24
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2074782150
- Cited by
- 136
- References
- 2
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practitioner attitudes to clozapine initiation. https://app.cochat.ai/papers/10.1111/acps.12193
- The paper
- Gee, S., Vergunst, F., Howes, O., & Taylor, D. (2014). Practitioner attitudes to clozapine initiation. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.